Moderna reports early immunogenicity data for bird flu jab as HHS pulls funding

bird flu. The announcement came in conjunction with an interim data readout from Moderna’s 300-person Phase I/II trial of its H5 avian influenza …

Read More at Source.

Pumilo
Author: Pumilo